Industry
New Study Shows Disparities In Lung Cancer Treatment Throughout Europe
June 2008 | Industry NewsPoor access to treatment and the fragmented management and organisation of lung cancer care in Europe is leading to poorer outcomes and a high burden for patients, according to a joint study by i3 Innovus, the Karolinska Institut and the Stockholm School of Economics. The study analysed the management of the disease in 20 European countries, comparing the outcomes of lung cancer care, the restrictions in patients' access to the most appropriate treatments and country policies promoting the use of different
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
